The goal of this activity is to provide education about immunotherapy in advanced CSCC that is not amenable to surgery or radiotherapy.
Upon completion of this activity, participants should be better able to:
Assistant Clinical Professor
Division of Dermatology
City of Hope
Duarte, California, United States
Clinical Investigator, Molecular Therapeutic Research Unit and ENT Unit
Vall d’Hebron University Hospital
Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain
Director, Clinical Research Phase 1 Clinical Trial Unit
START Madrid-FJD
Hospital Fundación Jiménez Díaz
Madrid, Spain
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
